Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
Stopped Lack of feasibility due to low recruitment
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG: Zileuton
- DRUG: Placebo
Sponsor
University of Minnesota
Collaborators